Introduction:  Non-alcoholic fatty liver disease (NAFLD) has been described in adult GH deficiency syndrome. Furthermore, chronic liver disease can be associated with significant changes in levels of IGF-I, GH-binding protein (GHBP), IGF-binding proteins (IGFBPs) and acid-labile subunit (ALS). However, the effect of liver steatosis on the GHBP production has not been investigated yet. Aim of the study:  to explore if GH secretion and/or levels of IGF-I, IGFBP-3, ALS and GHBP could be altered in obese patients in relation to the presence of liver steatosis. Materials and methods:  A total of 115 obese patients (BMI> 30) were enrolled in the protocol (65 patients with liver steatosis and 50 age- and BMI-matched controls). In all patients the following parameters were studied: serum levels of glucose, insulin, the HOMA index, IGF-I, GHBP, IGFBP-3, ALS and GH after GHRH and arginine stimulation test. Results:  As expected, subjects with NAFLD had blood glucose, insulin, HOMA-R significantly higher than controls, indicating a more severe insulin-resistance state in NAFLD. Furthermore, patients with NAFLD had higher levels of GHBP and IGFBP-3 and lower GH peak and IGF-I levels as compared to controls. No difference was found in ALS levels between the groups. In a multivariate analysis, GHBP was positively associated with hepatic steatosis while IGF-1 was negatively associated with hepatic steatosis. Conclusions:  This study demonstrates that in NAFLD patients the GHBP levels are increased and that the GH/IGF-I axis is significantly altered probably leading to reduced IGF-I bioavailability at tissue level.

Fusco, A., Miele, L., D'Uonnolo, A., Forgione, A., Riccardi, L., Cefalo, C., Barini, A., Bianchi, A., Giampietro, A., Cimino, V., Landolfi, R., Grieco, A., De Marinis, L., Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels, <<CLINICAL ENDOCRINOLOGY>>, 2011; 2011 (Novembre): 1365-1367. [doi:10.1111/j.1365-2265.2011.04291.x] [http://hdl.handle.net/10807/14203]

Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels

Fusco, Alessandra;Miele, Luca;Forgione, Alessandra;Riccardi, Laura;Cefalo, Consuelo;Barini, Angelina;Landolfi, Raffaele;
2011

Abstract

Introduction:  Non-alcoholic fatty liver disease (NAFLD) has been described in adult GH deficiency syndrome. Furthermore, chronic liver disease can be associated with significant changes in levels of IGF-I, GH-binding protein (GHBP), IGF-binding proteins (IGFBPs) and acid-labile subunit (ALS). However, the effect of liver steatosis on the GHBP production has not been investigated yet. Aim of the study:  to explore if GH secretion and/or levels of IGF-I, IGFBP-3, ALS and GHBP could be altered in obese patients in relation to the presence of liver steatosis. Materials and methods:  A total of 115 obese patients (BMI> 30) were enrolled in the protocol (65 patients with liver steatosis and 50 age- and BMI-matched controls). In all patients the following parameters were studied: serum levels of glucose, insulin, the HOMA index, IGF-I, GHBP, IGFBP-3, ALS and GH after GHRH and arginine stimulation test. Results:  As expected, subjects with NAFLD had blood glucose, insulin, HOMA-R significantly higher than controls, indicating a more severe insulin-resistance state in NAFLD. Furthermore, patients with NAFLD had higher levels of GHBP and IGFBP-3 and lower GH peak and IGF-I levels as compared to controls. No difference was found in ALS levels between the groups. In a multivariate analysis, GHBP was positively associated with hepatic steatosis while IGF-1 was negatively associated with hepatic steatosis. Conclusions:  This study demonstrates that in NAFLD patients the GHBP levels are increased and that the GH/IGF-I axis is significantly altered probably leading to reduced IGF-I bioavailability at tissue level.
2011
Inglese
Fusco, A., Miele, L., D'Uonnolo, A., Forgione, A., Riccardi, L., Cefalo, C., Barini, A., Bianchi, A., Giampietro, A., Cimino, V., Landolfi, R., Grieco, A., De Marinis, L., Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels, <<CLINICAL ENDOCRINOLOGY>>, 2011; 2011 (Novembre): 1365-1367. [doi:10.1111/j.1365-2265.2011.04291.x] [http://hdl.handle.net/10807/14203]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/14203
Citazioni
  • ???jsp.display-item.citation.pmc??? 30
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact